Ginecologia/Obstetrícia

Revisão | Quando operar após infecção por SARS-CoV-2?

23 Mar, 2022 | 12:02h

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA – Langenbeck’s Archives of Surgery

Conteúdos relacionados:

Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

---

Estudo mostra que é factível predizer o risco de doenças comuns via genoma completo na pré-implantação do embrião humano, o que leva a preocupações éticas.

23 Mar, 2022 | 12:00h

Whole-genome risk prediction of common diseases in human preimplantation embryos – Nature Medicine

Comentários convidados:

Polygenic embryo testing: understated ethics, unclear utility – Nature Medicine

The uncertain science of preimplantation and prenatal genetic testing – Nature Medicine

Comentário: As genetic testing of human embryos expand, researchers call for frank assessment of profound ethical implications – The Hastings Center

Conteúdo relacionado: Opinion | “The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice”.

 

Comentário no Twitter (fio – clique para saber mais)

Preimplantation genetic testing of human embryos is a rapidly advancing field, but scientists and ethicists are calling for caution.
We present 3 articles highlighting new research and expert commentary on this controversial topic.
THREAD 🧵

— Nature Medicine (@NatureMedicine) March 21, 2022

 

---

Padrões longitudinais de longo prazo da fadiga relatada pelas pacientes após câncer de mama.

23 Mar, 2022 | 11:44h

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis – Journal of Clinical Oncology

 

Comentário no Twitter

Congrats to @ines_vazluis, @dimeglio_anto & colleagues for another great publication from #CANTO! Here, they describe different patterns of fatigue developed after BC. Great to know that most pts (60%) fare well. We need to do better for those that don’t.https://t.co/VxxJvjECw9

— Paolo Tarantino (@PTarantinoMD) March 16, 2022

 

---

Estudo randomizado | Levotiroxina não é benéfica para mulheres eutireóideas com anticorpo positivo para peroxidase tireóidea e perda gestacional recorrente.

23 Mar, 2022 | 11:39h

Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Diabetes & Endocrinology (link para o resumo – $ para o texto completo)

Comentário: Levothyroxine No Boon for Birth Rates in Women With Possible Thyroid Disorder – MedPage Today (necessário cadastro gratuito)

---

Incidência de recidiva de câncer de mama 10-32 anos após o primeiro diagnóstico.

23 Mar, 2022 | 11:34h

The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis – JNCI: Journal of the National Cancer Institute

---

Estudo multicêntrico de coorte retrospectiva | Desfechos e segurança do rastreamento baseado no histórico para aborto medicamentoso.

23 Mar, 2022 | 11:32h

Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study – JAMA Internal Medicine

Comentário convidado: It Is Time to Change the Standard of Medication Abortion – JAMA Internal Medicine (gratuito por tempo limitado)

---

M-A | Risco de carcinomatose peritoneal após redução do risco por salpingo-ooforectomia em portadoras da variante patogênica BRCA1/2.

23 Mar, 2022 | 11:24h

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis – Journal of Clinical Oncology

---

Diretriz | Cuidados com o cordão umbilical em recém-nascidos prematuros e a termo.

22 Mar, 2022 | 11:43h

Guideline No. 424: Umbilical Cord Management in Preterm and Term Infants – Journal of Obstetrics and Gynaecology Canada

---

Estudo mostra baixo risco de complicações após colocação de cateter intravenoso ipsilateral em pacientes cirúrgicas de câncer de mama.

21 Mar, 2022 | 16:26h

Ipsilateral Intravenous Catheter Placement in Breast Cancer Surgery Patients – Anesthesia & Analgesia (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

🙏🙏🙏 much-needed dogmalysis. I’ve seen situations where folks were afraid to even place a Bp cuff ipsilateral to prior mastectomy. this excessive fear impairs patient care. https://t.co/afjwjjseo7

— 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊 (@PulmCrit) March 17, 2022

 

---

Plano de cuidado multidisciplinar do câncer de ovário em pacientes idosos.

21 Mar, 2022 | 15:59h

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO – Cancers

---